Hysterectomy (even with ovaries conserved) harms the heart and metabolism; uterus and ovaries form a hormonal network protecting heart, brain and bone.
Original statement
والرحم والمبيضان جزء من شبكة هرمونية تحمي القلب والدماغ والعظام
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Hysterectomy (even with ovaries conserved) harms the heart and metabolism; uterus and ovaries form a hormonal network protecting heart, brain and bone.
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (eltayebat.com); not necessarily Elawady's own words
- Origin
- https://eltayebat.com/rule/unnecessary-organ-removal/
- Attribution uncertainty
- Editorial summary/narrative and study selection written by the archive operators; the archive states that the cited research documents harm independently of Dr. Diaa's words.
- Claimed mechanism
Hormonal network.
- Claimed health effect
Cardiovascular and metabolic disease.
- Population concerned
Women with benign hysterectomy
- Geographic restriction by Elawady
not applicable
Scientific assessment
Potentially true – Some evidence points in favour of the statement, but it is not sufficient for a clear judgement.
Certainty of evidence: low – Further research is likely to change the assessment considerably.
1. What was claimed?
Hysterectomy harms heart and metabolism.
2. What is demonstrably correct?
CVD HR 1.18 in women <50 (A-ORG-10); CAD HR 1.33 and other metabolic conditions even with ovarian conservation, especially <=35 years (A-ORG-11).
3. What is wrong or exaggerated?
Hysterectomy was not associated with increased mortality over >20 years (A-ORG-12, archive-cited but not discussed). No association in women >=50 (A-ORG-10). The 'protective hormonal network' of the uterus is a hypothesis not tested by these studies.
4. What remains unclear?
Causality; mechanisms in ovary-conserving hysterectomy.
5. Which studies support it?
6. Which studies contradict it?
7. What applies to Germany and Europe?
Most cited cohorts are Scandinavian (Denmark, Sweden) and directly European; RCTs from the UK and Finland are directly transferable. Guidelines in Europe also emphasize defined indications (not verified here in detail).
8. What is known about Egypt?
No Egypt-specific data on rates or outcomes of tonsillectomy, cholecystectomy, hysterectomy, splenectomy or thyroid surgery were identified in this review.
9. What practical conclusion is appropriate?
Supports considering alternatives for benign conditions in young women.
Assessment details
- Rationale for certainty of evidence
Several cohorts show modestly higher CVD after hysterectomy in younger women; an archive-cited cohort found no increase in mortality.
- Source quality
Archive-cited Iversen 2005 (null mortality) is not mentioned in the narrative.
- Regional transferability
Swedish and UK data.
- Individual exceptions
Associations mainly in women operated before 50 (or <=35).
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 25 October 2026 provisional
In plain language
The archive says removing the uterus harms the heart and metabolism. Some large studies found modestly more heart disease later, especially when the operation was done before age 50. However, another study cited by the archive itself found no increase in deaths over 20 years. The evidence suggests a possible risk, mostly in young women, but not proof.
Studies on this claim
Studies supporting the claim (2)
-
Hysterectomy and heart disease in Sweden
Ingelsson E et al.. Eur Heart J 2011 · PMID 21186237 · DOI 10.1093/eurheartj/ehq477Cohort studycited by the Tayebat archiveabstract only checkedWomen operated before 50 had about 18% more cardiovascular disease later.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
CVD
- How was the study done?
Register
- How many people, animals or samples were studied?
824,484
- What was actually found?
Higher CVD <50
- How large was the observed effect?
HR 1.18
- What do the results mean in everyday life?
Possible long-term cost
- What are the study's limitations?
Confounding
- What does it say about Elawady's specific claim?
Supports association
- Do the results apply to Germany and Europe?
European
- What can explicitly not be concluded from this study?
Causation
-
Hysterectomy with ovaries kept
Laughlin-Tommaso SK et al.. Menopause 2018 · PMID 29286988 · DOI 10.1097/GME.0000000000001043Cohort studycited by the Tayebat archiveabstract only checkedLater heart and metabolic problems were modestly more frequent, especially after surgery at age 35 or younger.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
CV risk
- How was the study done?
Cohort
- How many people, animals or samples were studied?
4188
- What was actually found?
Modest increase
- How large was the observed effect?
CAD HR 1.33
- What do the results mean in everyday life?
Consider alternatives when possible
- What are the study's limitations?
Observational
- What does it say about Elawady's specific claim?
Supports association
- Do the results apply to Germany and Europe?
Applicable
- What can explicitly not be concluded from this study?
Causation
No study in this group is marked as key.
Studies contradicting or limiting the claim (1)
-
UK: hysterectomy and death risk
Iversen L et al.. BMJ 2005 · PMID 15930026 · DOI 10.1136/bmj.38483.669178.8FCohort studycited by the Tayebat archiveabstract only checkedWomen who had a hysterectomy did not die earlier over about 20 years.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Mortality
- How was the study done?
Nested cohort
- How many people, animals or samples were studied?
7410
- What was actually found?
No increase
- How large was the observed effect?
HR 0.94/0.82
- What do the results mean in everyday life?
No mortality penalty found
- What are the study's limitations?
Ovary status unclear
- What does it say about Elawady's specific claim?
Limits claim
- Do the results apply to Germany and Europe?
European
- What can explicitly not be concluded from this study?
CVD morbidity
No study in this group is marked as key.
Studies with mixed or unclear results (0)
No studies in this group.
Regional context
Germany / EU
Most cited cohorts are Scandinavian (Denmark, Sweden) and directly European; RCTs from the UK and Finland are directly transferable. Guidelines in Europe also emphasize defined indications (not verified here in detail).
Egypt
No Egypt-specific data on rates or outcomes of tonsillectomy, cholecystectomy, hysterectomy, splenectomy or thyroid surgery were identified in this review.
What applies in my country?
General scientific assessment
Potentially true Possible modest risk in younger women; mortality not increased.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Hysterectomy and risk of cardiovascular disease: a population-based cohort study.. Ingelsson E et al.. Eur Heart J 2011 · PMID 21186237 · DOI 10.1093/eurheartj/ehq477
- Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.. Laughlin-Tommaso SK et al.. Menopause 2018 · PMID 29286988 · DOI 10.1097/GME.0000000000001043
- Long term effects of hysterectomy on mortality: nested cohort study.. Iversen L et al.. BMJ 2005 · PMID 15930026 · DOI 10.1136/bmj.38483.669178.8F